Medication therapy management of patients with spinal muscular atrophy during the perioperative period of scoliosis correction surgery
Spinal muscular atrophy(SMA),a devastating hereditary neuromuscular disease,is often complicated by scoliosis.While scoliosis correction surgery is frequently indicated to correct spinal deformities,it is not without significant risks,including the potential for infection,hemorrhage,and neurological damage.Consequently,the management of perioperative medications is of paramount importance for the prevention and control of these complications,as well as for facilitating patient recovery.However,the distinctive physiological and pathological characteristics of SMA,coupled with the lack of standardized protocols,present considerable challenges in perioperative medication management.This review article offers an in-depth examination of the perioperative medication therapy management for patients with SMA undergoing scoliosis surgery.It aims to establish an evidence-based framework and provide a reference for the judicious use of drugs in clinical settings.
万方数据
维普
